Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Biocare Medical, LLC CA 19-9 Antibody - Concentrate, 0.1 ml
Supplier: Biocare Medical, LLC CM123A
CA 19-9 antibody, a carbohydrate antigenic determinant identified as a sialylated lacto-N-fucopentose II, is related to the Lewis blood group. CA 19-9 might play a role in the process of tumor progression as an adhesion molecule. The CA 19-9 antibody has been shown to label adenocarcinomas of the pancreas, stomach, breast, colon and gall bladder. CA 19-9 is also expressed in primary and metastatic ovarian carcinomas. Studies show that CA 19-9 positive expression may be a predictor of increased cancer mortality.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?